Marko S. Zatylny

Partner

Zatylny-Marko-300
  • JD, Harvard Law School, 2002
  • BS (Accounting), magna cum laude, Brigham Young University, 1998

Qualifications

  • Massachusetts, 2002
  • LMG Life Sciences Stars (2016)
  • Legal 500 (2016)
  • “Dealmaker of the Week” The American Lawyer (2015)
  • IFLR1000: The Guide to the World’s Leading Financial Law Firms, Rising Star (2014-2018)
  • “Dealmaker of the Week” The American Lawyer (2012)

Marko S. Zatylny

Partner

Marko focuses his practice on advising public and private companies, investment banks and investment funds in mergers & acquisitions, capital markets transactions and corporate governance issues. He handles transactions for clients in a number of industries, including life sciences, financial services, energy/infrastructure and retail and consumer. His clients include companies such as Becton, Dickinson and Company (BD), Eversource Energy, Domino’s Pizza, LPL Financial, MACOM Technology Solutions, Pfizer, Veolia Energy and Verastem. Marko is co-chair of the firm’s energy/infrastructure group. In April 2012 and February 2015, Marko was named “Deal Maker of the Week” by The American Lawyer.

Experience

  • Eversource Energy in its acquisition of Aquarion Water Company, the largest private water company in the New England region, for $1.675 billion including debt.
  • BD, most recently in its acquisitions of Alverix, GenCell Biosystems and CRISI Medical Systems and its divestitures of its Discovery Labware business to Corning, its sterile injectable business to Fresenius Kabi and its vertebral augmentation business to Stryker.
  • MACOM Technology Solutions in its acquisition of Applied Micro Circuits Corporation and its acquisition of Aeroflex Metelics. 
  • Eversource Energy in its joint venture with DONG Energy, the global leader in offshore wind power, to develop deepwater offshore wind farms off the coast of the New England states.
  • Veolia Energy in its acquisition of Enovity, a building commissioning and energy services company.
  • Novavax in its cross-border tender offer for the outstanding shares of Isconova, a Sweden-based publicly traded vaccine adjuvant company.
  • Pfizer in its acquisition of Hospira for approximately $17 billion and its acquisition of Excaliard Pharmaceuticals.
  • Wright Medical in its merger of equals with Tornier NV and with the sale of its OrthoRecon business to Hong Kong-based MicroPort Scientific Corporation.
  • Veolia Energy and I Squared Capital in their joint acquisition of the Kendall Square Power Station, a 256 megawatt producer of electrical and steam energy.
  • The lead underwriters in the $214 million IPO for Multi Packaging Solutions International.
  • DAVIDsTEA, Inc., a retailer of loose-leaf teas, pre-packaged teas, and tea-related gifts and accessories, in its $96 million IPO.
  • The lead underwriters in the $1 billion follow-on offering for HD Supply Holdings.
  • The lead underwriters in the initial public offering of Cerulean Pharma.
  • The lead underwriters in the follow-on offering of Insmed Incorporated.
  • The lead underwriters in the initial public offering and subsequent follow-on offerings of Bloomin’ Brands, one of the largest casual dining restaurant companies in the world.
  • LPL Financial, the nation's largest independent broker-dealer, in its $522 million initial public offering and subsequent follow on offerings. Also represented LPL Financial in its acquisition of Concord Wealth Management.
  • Covidien in its $2.6 billion acquisition of ev3, Inc. 
  • Represented clients in acquisitions of energy/utility assets and the negotiation of various power and energy contracts, including in the renewable energy sector.

Publications

Presentations

  • Panelist, “From the Boardroom: Considerations in Option to Purchase Deals,” Ropes & Gray Life Sciences Roundtable, San Francisco, January 12, 2014